A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk



Status:Recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - 80
Updated:3/8/2019
Start Date:February 12, 2018
End Date:February 1, 2021
Contact:Phoebe Finneran, BS
Email:pfinneran1@mgh.harvard.edu
Phone:6177261256

Use our guide to learn which trials are right for you!

The investigators aim to evaluate Wellframe, a patient engagement platform that includes a
mobile phone application for patients, for its impact on supporting patients who have
undergone a percutaneous coronary intervention. The patient mobile app has articles about
cardiovascular disease and other health related topics, patient-reported outcomes surveys,
physical activity tracking, reminders for medications and upcoming appointments, and two-way
communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages
patients to achieve their health goals and stay engaged in their health. The feasibility of
onboarding patients to the app and the clinical efficacy of the platform will be evaluated.


Inclusion Criteria:

English-speaking PCI: balloon angioplasty, bare-metal stent, or drug-eluting stent at MGH
Smartphone or Tablet (iOS or Android)

Exclusion Criteria:

Recent (within 1mo) illicit substance use or alcohol abuse In-hospital AMI Known pregnancy
Dementia or cognitive disability Incarceration
We found this trial at
2
sites
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: Stephen Wiviott, MD
Phone: 617-726-1256
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02114
Principal Investigator: Pradeep Natarajan, MD, MMSc
Phone: 617-726-1256
?
mi
from
Boston, MA
Click here to add this to my saved trials